Protalix CFO to Present at H.C. Wainwright, Morgan Stanley Healthcare Conferences
Image
Carmiel, Israel – September 11, 2026 -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) confirmed that Chief Financial Officer Gilad Mamlok will represent the company at two investor conferences in New York City this month.
Mamlok addresses H.C. Wainwright's 28th Annual Global Investment Conference on September 14
The presentation is scheduled for 2:00 p.m. EDT during the three-day event running September 14-16, 2026.
Morgan Stanley's 24th Annual Global Healthcare Conference hosts a fireside chat on September 16
The session is set for 1:05 p.m. EDT and will be streamed via a live audio webcast, with an archived replay available afterward on Protalix's investor relations site.